Long-term Safety of SPD422 in Japanese Adults With Essential Thrombocythaemia
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to provide SPD422 to subjects who completed Study SPD422 308
and, in the opinion of the Investigator, will continue to benefit from treatment.